SCHEMBL5068381

SCHEMBL5068381

O=S(=O)(O)c1ccccc1.c1ccc(C2CCCCO2)cc1

nearest known ligand 0.48

Known targets — ChEMBL curated mechanism

BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
PKM P14618 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CYP2C19 P33261 1/20 0.40
MCOLN2 Q8IZK6 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.39
MCOLN1 Q9GZU1 1/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
SLC6A3 Q01959 2/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
PRKAB2 O43741 2/20 0.37
PRKAG1 P54619 2/20 0.37
PRKAA2 P54646 2/20 0.37
PRKAA1 Q13131 2/20 0.37
PRKAG3 Q9UGI9 2/20 0.37
PRKAG2 Q9UGJ0 2/20 0.37
PRKAB1 Q9Y478 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578672 0.89 KCNH2 (0.44) TSHRSMN1; SMN2ALDH1A1KCNH2HRH3
SCHEMBL28416 0.83 TSHR (0.54) TSHRSMN1; SMN2ALDH1A1KCNH2HRH3
SCHEMBL18388973 0.83 TSHR (0.54) TSHRSMN1; SMN2ALDH1A1KCNH2HRH3
SCHEMBL18215382 0.83 TSHR (0.54) TSHRSMN1; SMN2ALDH1A1KCNH2HRH3
SCHEMBL1266842 0.82 TSHR (0.52) TSHRSMN1; SMN2ALDH1A1KCNH2HRH3
SCHEMBL5069254 0.80 TSHR (0.50) TSHRSMN1; SMN2PKMALDH1A1CYP2C19
SCHEMBL29028819 0.79 TSHR (0.48) TSHRSMN1; SMN2PKMALDH1A1L3MBTL1
SCHEMBL17414393 0.78 TSHR (0.56) TSHRSMN1; SMN2CYP2C19KCNH2HRH3
SCHEMBL28414 0.78 TSHR (0.56) TSHRSMN1; SMN2CYP2C19KCNH2HRH3
SCHEMBL5070898 0.77 ALDH1A1 (0.50) TSHRSMN1; SMN2PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365215-B2 Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same UBE INDUSTRIES, LTD. (JP) 2008-04-29 US disclosed
US-20070106083-A1 Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same UBE INDUSTRIES, LTD. (JP) 2007-05-10 US disclosed
EP-1661894-A1 PROCESS FOR PRODUCTION OF 4-AMINOTETRAHYDROPYRANS AND SALTS THEREOF WITH ACIDS, INTERMEDIATES FOR THE PROCESS, AND PROCESS FOR PRODUCTION THEREOF Ube Industries, Ltd. (JP) 2006-05-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070106083-A1 Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same PAH, HPD, REN TSHR 3997/4885SMN1; SMN2 3594/4885PKM 2550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.